47 results about "De novo sequencing" patented technology

The present invention provides a miniaturized integrated nucleic acid diagnostic device and system. The device of the invention is generally capable of performing one or more sample acquisition and preparation operations, in combination with one or more sample analysis operations. For example, the device can integrate several or all of the operations involved in sample acquisition and storage, sample preparation and sample analysis, within a single integrated unit. The device is useful in a variety of applications, and most notably, nucleic acid based diagnostic applications and de novo sequencing applications.

The present disclosure provides methods, compositions, and kits for methods that can improve techniques nucleic acid analysis, and can allow for more reliable and accurate targeted, multiplexed, high throughput sequencing. The methods, compositions, and kits can be used for sequencing target loci of nucleic acid. The methods, compositions, and kits disclosed herein can be used for assisted de novo targeted sequencing. The methods, compositions, and kits disclosed herein can also be used for library labeling for de novo sequencing and phasing.

The invention provides a building method of a long fragment nucleic acid library. The method comprises the following steps: preparing a batch of Index label clusters, marking long fragment nucleic acid molecules in batch, using whole genome resequencing library building to build long fragment libraries suitable for illumine sequencing platforms, allowing all fragments to have connectors suitable for the illumine sequencing platforms under the action of transposase, carrying out PCR amplification, and screening the well build library. The method effectively solves the problem of influences of polyploid and repeated sequence in a genome de novo sequencing technology on the assembling accuracy, and can be used for assembling complex genomes and assisting de novo sequencing assembling to improve the assembling accuracy and shorten the assembling time.

The invention provides a method and a system based on an HCD mass spectrogram and an ETD mass spectrogram for peptide fragment de novo sequencing. The method includes steps of: (1) homologizing the HCD mass spectrogram and the ETD mass spectrogram to form a new mass spectrum, pretreating the new mass spectrum, detecting effective spectral peaks and deleting interference peaks; (2) constructing a directed acyclic graph according to the effective spectral peaks; (3) searching a route conforming the weight roles in the directed acyclic graph, and generating candidate peptide fragments according to the route; and (4) matching the candidate peptide fragments and the new mass spectrum, grading, sequencing the candidate peptide fragments according to the grading results, and outputting. The method and the system overcome disadvantages of defective spectral peaks caused by single fracture types, combine advantages of the HCD mass spectrogram and the ETD mass spectrogram, and increase the accuracy of the de novo sequencing. Pretreatment is performed before de novo sequencing to remove many isotope spectral peaks and noise spectral peaks, thus preventing the isotope spectral peaks and the noise spectral peaks from interfering the de novo sequencing algorithm. A grading algorithm with a high distinction degree is adopted, thus improving the performance of the de novo sequencing.

The present invention relates to a polypeptide amino acid sequence De novo sequencing method based on chemical modification and isotope labeling, wherein the MS/MS maps of the same polypeptides having different labels are subjected to correlation by using the correlation between the N-terminal labeling and C-terminal labeling polypeptide molecule quality and the retention time, the polypeptides in different labeled samples form N-terminal fragment ion pair and the C-terminal fragment ion pair during a mass spectrometry fragmentation process, and the polypeptide amino acid sequence is subjected to De novo sequencing. According to the present invention, the polypeptide is modified with the positively charged reagent so as to make the polypeptide easily form the rich fragment ions in the mass spectrometry during fragmentation, and by using the reagents containing different light and weight isotopes to label, the polypeptide form the paired fragment ions in the mass spectrometry during fragmentation so as to be easily distinguished, such that the influence of the interfering signal is reduced, and the fragment ion selection specificity and the De novo sequencing speed can be improved; and by using the complementarity of the N-terminal fragment ions and the C-terminal fragments, the accuracy and the efficiency of the polypeptide sequencing can be improved.

The present invention provides for methods, reagents, apparatuses, and systems for the replication or amplification of nucleic acid molecules from biological samples. In one embodiment of the invention, the nucleic molecules are isolated from the sample, and subjected to fragmenting and joining using ligating agents of one or more hairpin structures to each end of the fragmented nucleic molecules to form one or more dumbbell templates. The one or more dumbbell templates are contacted with at least one substantially complementary primer attached to a substrate, and subjected to rolling circle replication or rolling circle amplification. The resulting replicated dumbbell templates or amplified dumbbell templates are used in numerous genomic applications, including whole genome de novo sequencing; sequence variant detection, structural variant detection, determining the phase of molecular haplotypes, molecular counting for aneuploidy detection; targeted sequencing of gene panels, whole exome, or chromosomal regions for sequence variant detection, structural variant detection, determining the phase of molecular haplotypes and/or molecular counting for aneuploidy detection; study of nucleic acid-nucleic acid binding interactions, nucleic acid-protein binding interactions, and nucleic acid molecule expression arrays; and testing of the effects of small molecule inhibitors or activators or nucleic acid therapeutics.

The embodiment of the invention provides a genome sequencing data sequence assembling method. By means of the method, the advantages of denovo sequencing and the advantages of re-sequencing can be integrated, and genome sequencing data sequences are effectively assembled. A drafted sequence traversal path of the genome sequencing sequences obtained based on a reference sequence and generated after sequencing data are mapped to the reference sequence in a comparing mode and an overlapping relation set of the genome sequencing data are known. The set comprises a determined relation subset and an undetermined relation subset. The method includes the steps that after the sequencing data sequences are mapped to an affinis reference genome in a comparing mode, the drafted data traversal path of the genome sequencing sequences is obtained based on the reference sequence, all nodes in the drafted sequence traversal path are checked one by one; iterated revision is conducted on the drafted sequence traversal path according to the connection relation of the determined relation subset and/or the undetermined relation subset in the overlapping relation set, and the overlapping relation set is updated; the next node is checked based on the updated drafted sequence traversal path and the updated overlapping relation set till the last node is checked.

The invention relates to an assembling method for de novo sequencing data based on an optics map platform Irys. The method comprises: using the optics map platform Irys to obtain a gene assembly file; getting a scaffold file: fai file of NGS; preprocessing data: through setting a threshold value, filtering a comparison result whose confidence level is low, combining cmap files, sorting, calculating N50; counting assembling effects: counting comparison results of BioNano and NGS, including the contig of the BioNano, and the length, number, and total quantity of scaffold of NGS; according to the contig of the BioNano and network topological relations among the scaffold of the NGS, analyzing length of the assembled new contig and length of scaffold in a classified manner. The method can assist genome assembly, and obviously improves gene assembly effects of species.

The present invention provides a method for specifically recovering a C-terminal peptide fragment, and a method for easily determining the sequence of a C-terminal peptide fragment, which is difficult to be determined by a conventional method, with the use of a mass spectrometer, in particular a method capable of de novo sequencing of a C-terminal peptide fragment. A method for selectively recovering a C-terminal peptide of a protein, comprising the steps of: in a cleavage product of a protein containing a C-terminal peptide fragment (A) having an α-amino group but not having an ε-amino group and the other peptide fragments (B) having an α-amino group and an ε-amino group, selectively modifying the α-amino groups to obtain a C-terminal peptide fragment modified (A′) and the other peptide fragments modified (B′); and separating the C-terminal peptide fragment modified (A′) from the modified cleavage product by allowing a carrier to hold the other peptide fragments modified (B′) via the ε-amino group. A method for determining the amino acid sequence of a C-terminal peptide of a protein, comprising the steps of: selectively recovering a C-terminal peptide of a protein by the above method; and determining the amino acid sequence by subjecting a recovered C-terminal peptide fragment to mass spectrometry measurement.

The present invention relates to a method of peptide sequencing by MALDI (matrix-assisted laser desorption ionization) tandem mass spectrometry, which comprises the steps of chemically modifying a sample peptide with at least one chemical modification method selected from the group consisting of guanidination and esterification in order to change the ionization status of the peptide and performing mass spectrometry using a MALDI tandem mass spectrometer and programmed MALDI tandem mass spectrometry. The peptide sequencing method of the present invention is advantageous in that detection sensitivity of the peptide improves significantly and various daughter ions are detected uniformly, thereby enabling perfect de novo sequencing with tandem mass spectrometry only, without database search.

Independent of scoring algorithm for matching or correlating mass spectrometer outputs to peptides in database(s), methods for identifying when a scoring algorithm has achieved a successful correlation include identifying criteria indicative of the successful correlation, conducting a plurality of scoring algorithm runs or analyses, and making an in silico determination as to whether the criteria is met. A first analysis occurs with initial parameters while subsequent analyses occur with modified parameters and/or other scoring algorithms. Parameters include spectrum data conditioning parameters applicable to mass spectrometer outputs and/or peptide data conditioning parameters applicable to peptides or their database. Preferred criteria indicating successful correlation include meeting a threshold algorithm score, obtaining a desired peptide coverage percentage or obtaining an amount of spectrum coverage used in matching. De novo sequencing information may also be used. Computer readable media and computing system environments are some embodiments for performing the invention.

The invention provides an automatic analysis method for bacterial whole genome sequencing data, which comprises the following steps: acquiring bacterial genome sequencing data, and judging the type of the sequencing data; respectively carrying out corresponding preprocessing according to the type of the sequencing data; performing re-sequencing analysis and de novo sequencing analysis on the preprocessed sequencing data according to an analysis type selected by a user and preset tool software and software parameters; and realizing the identification and annotation of the whole genome of the bacteria. The scheme provides a user-friendly automated analysis method, for researchers and clinicians without professional bioinformatics knowledge, automated bioinformatics analysis steps including sequencing quality control, re-sequencing and de novo assembly, similar bacterial reference genome identification, bacterial genome annotation, and at the same time, researchers and clinicians without professional bioinformatics knowledge; meanwhile, customized bioinformatics analysis can be carried out according to short-read-length and long-read-length sequencing data generated by different platforms, and an accurate analysis result is obtained.

The invention provides a denovo sequencing method. The method comprises the following steps: transforming a to-be-analyzed spectrogram into a mass spectrum connection diagram, counting the score of each path in the mass spectrum connection diagram, extracting a plurality of front normal paths with high path score and a modification path as a candidate peptide fragment, wherein the normal path is the path only formed by normal sides, and the modification path is the path formed by the normal side and a modification side, and only contains one modification side; performing peptide spectrum matching scoring on each candidate peptide fragments, and taking the candidate peptide fragment with the highest peptide spectrum matching scoring as the peptide fragment corresponding to the spectrogram. By use of the method disclosed by the invention, the discovery of thousands of accident modificaitons can be supported without greatly influencing the peptide fragment identification speed; furthermore, the similar peptide fragment sequences can be distinguished in finer granularity, and the accuracy rate of the peptide identification is improved.

The invention provides a development method and the application of a siniperca chuatsi sex specific marker. The development method comprises the following steps: (1) obtaining male and female siniperca chuatsi specific short sequences as shown in SEQ ID NO.1 by utilizing a high-throughput sequencing method based on a 2b RAD technology; (2) obtaining a male siniperca chuatsi whole genome sequence by using a high-throughput de novo sequencing method; and (3) searching the male siniperca chuatsi specific short sequence obtained in the step (1) in the male siniperca chuatsi whole genome sequence obtained in the step (2) to obtain a longer male siniperca chuatsi specific sequence, namely SEQ ID NO.2, and performing later primer design to be applied to genetic sex identification of siniperca chuatsi. The method has the advantages of quickness, directness, simplicity, convenience and the like, and sex molecular identification can be performed on a large number of samples.